CRH Medical Corporation (CRM:TSX-V) announced today that the Japanese Patent Office has provided a Notice of Allowance for a patent application filed by the Company and related to CRH Medical's hemorrhoid technology, the CRH O'Regan System(TM). The Japanese patent is expected to be issued in the next several weeks and will provide additional protection to the Company's proprietary technology platform.
Edward Wright, Chief Executive Officer of CRH Medical states, "Japan is one of many countries we have under review for further international distribution opportunities and the granting of patent rights, such as this one in Japan, is an important part of our overall strategy. Our goal internationally is to replicate our U.S. strategy of identifying key opinion leaders as early adopters and leverage their experience to help drive demand. Additionally, we are looking for distribution partners who have the same commitment to training, support, and patient education as CRH. We believe our proprietary platform has worldwide potential and, as evidenced by our recent expansion to China, we plan to take advantage of our unique position and strong portfolio of intellectual properties to grow our business."
SOURCE CRH Medical Corporation